Dafazin M-500

Composition: Dapagliflozin 10 mg + Metformin 500 mg

Dafazin M500 is a dual-action anti-diabetic formulation designed for effective control of Type 2 Diabetes Mellitus. This combination brings together two proven therapies: Metformin, which decreases liver glucose production and improves insulin sensitivity, and Dapagliflozin, an SGLT2 inhibitor that reduces blood sugar by promoting glucose excretion through urine. Dafazin M500 helps lower fasting and post-meal sugar levels, supports weight reduction, and contributes to cardiovascular and kidney protection in suitable patients. It is typically prescribed as part of a long-term diabetes management plan that includes proper diet, physical activity, and regular blood glucose monitoring.

Uses:

• Effective management of Type 2 Diabetes Mellitus
• Reduction in HbA1c levels
• Controls fasting and post-prandial sugar
• Helps in weight management
• Supports heart and kidney health in eligible patients

Side Effects:

• Stomach discomfort, nausea, diarrhea (Metformin-related)
• Frequent urination
• Genital fungal or urinary tract infections
• Dehydration or dizziness
• Rare: lactic acidosis (Metformin)
• Rare: ketoacidosis (Dapagliflozin)

Other Details:

• Not suitable for Type 1 diabetes
• Should not be used in severe kidney impairment
• Take with meals to minimize gastric irritation
• Maintain adequate hydration
• Dose adjustment may be required with insulin or other oral anti-diabetics